Publication:
Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models.

dc.contributor.authorNascimento, Roberto de Paula do
dc.contributor.authorMachado, Ana Paula da Fonseca
dc.contributor.authorGalvez, Julio
dc.contributor.authorCazarin, Cinthia Baú Betim
dc.contributor.authorMaróstica Junior, Mario Roberto
dc.date.accessioned2023-02-09T09:37:29Z
dc.date.available2023-02-09T09:37:29Z
dc.date.issued2020-07-25
dc.description.abstractUlcerative colitis (UC) is an inflammatory bowel disease with increasing incidence in the world, especially in developing countries. Although knowledge of its pathogenesis has progressed over the last years, some details require clarification. Studies have highlighted the role of microbial dysbiosis and immune dysfunction as essential factors that may initiate the typical high-grade inflammatory outcome. In order to better understand the immunopathophysiological aspects of UC, experimental murine models are valuable tools. Some of the most commonly used chemicals to induce colitis are trinitrobenzene sulfonic acid, oxazolone and dextran sodium sulfate. These may also be used to investigate new ways of preventing or treating UC and therefore improving targeting in human studies. The use of functional foods or bioactive compounds from plants may constitute an innovative direction towards the future of alternative medicine. Considering the above, this review focused on updated information regarding the 1. gut microbiota and immunopathogenesis of UC; 2. the most utilized animal models of the disease and their relevance; and 3. experimental application of natural products, not yet tested in clinical trials.
dc.identifier.citationNascimento RPD, Machado APDF, Galvez J, Cazarin CBB, Maróstica Junior MR. Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models. Life Sci. 2020 Oct 1;258:118129.
dc.identifier.doi10.1016/j.lfs.2020.118129
dc.identifier.essn1879-0631
dc.identifier.pmid32717271
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.lfs.2020.118129
dc.identifier.urihttp://hdl.handle.net/10668/16005
dc.journal.titleLife sciences
dc.journal.titleabbreviationLife Sci
dc.language.isoen
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.page.number118129
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0024320520308808?via%3Dihub
dc.rights.accessRightsopen access
dc.subjectBioactive compounds
dc.subjectDextran sodium sulfate
dc.subjectFunctional foods
dc.subjectInflammation
dc.subjectInflammatory bowel diseases
dc.subjectMicrobiota
dc.subjectNatural products
dc.subjectOxazolone
dc.subjectTrinitrobenzene sulfonic acid
dc.subject.decsColitis Ulcerosa
dc.subject.decsDisbiosis
dc.subject.decsModelos Animales de Enfermedad
dc.subject.decsMicrobiota Intestinal
dc.subject.decsCompuestos Bioactivos
dc.subject.decsCompuestos Bioactivos
dc.subject.meshAnimals
dc.subject.meshBiological Products
dc.subject.meshColitis, Ulcerative
dc.subject.meshDisease Models, Animal
dc.subject.meshGastrointestinal Microbiome
dc.subject.meshHumans
dc.subject.meshModels, Biological
dc.titleUlcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number258
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format